Dynamic scheduling of the upcoming screening exam based on screening history and other parameters
Dynamic scheduling of the upcoming screening exam based on screening history and other parameters
批准号:
9810977
负责人:
Dongfeng Wu
金额:
$43.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31
关键词:
AddressAgeChronic DiseaseClinicalComputer softwareDiagnosisDiseaseEarly DiagnosisFemaleFoundationsFrequenciesFutureGenderGoalsIncidenceIndividualKnowledgeLeadLikelihood FunctionsLungMalignant NeoplasmsMalignant neoplasm of lungMethodsModalityModelingMotivationOutputPatientsPersonsPhysiciansPlug-inPolicy MakerProbabilityProstate, Lung, Colorectal, and Ovarian Cancer Screening TrialPulmonary MassRecording of previous eventsResearchRiskRisk FactorsRoentgen RaysScheduleScreening ResultScreening for cancerSmokerSmoking StatusSpiral Computed TomographyStatistical MethodsTechniquesTestingThoracic RadiographyTimeValidationX-Ray Computed Tomographybasecohortdensitylow-dose spiral CTlung cancer screeningmalenever smokerpre-clinicalscreeningsimulationsoftware developmenttime intervaltrial designtv watchinguser friendly software
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Motivated by the need of physicians and patients to make informed decision, probability methods are proposed
to address the problem of when to schedule the next exam for an asymptomatic individual with a history of
negative screenings. The method provides a screening time interval to limit the risk of being a clinical incident
case to a small value, such as 5% or 10%. The time interval is a function of the three key parameters (i.e.,
screening sensitivity, sojourn time in preclinical state and transition time distribution in disease-free state), a
person's current age/gender, smoking status, and one's screening history. Distribution of Lead time (ie.
diagnosis time advanced by screening) and probability of over-diagnosis are derived, if one would be
diagnosed with cancer at the future scheduled time. A new likelihood function to estimate the three key
parameters are proposed and will be validated to increase the accuracy of the estimation. The methods will be
applied to four cohorts from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial for lung cancer
(PLCO-Lung) and four cohorts from the National Lung Screening Trials (NLST). The specific aims are:
1. To estimate the three key parameters using a new likelihood function in the eight cohorts using either chest
X-ray or Low Dose Computed Tomography (CT). Eight cohorts (four from PLCO-Lung using X-ray:
male/female smokers, male/female never-smokers; four from NLST: male/female smokers via X-ray,
male/female smokers via CT) were identified. The three key parameters will be estimated when sensitivity
is modeled as a function of the sojourn time and time spent in the preclinical state using our new likelihood
method. This lays a foundation for predictions and estimations in Aim 2, since the future time interval is a
function of the three key parameters; and we will plug in estimates of the three key parameters in Aim 2 to
obtain the optimal screening time.
2. To schedule the next screening exam dynamically for an asymptomatic individual with any screening
history. A new method using conditional probability of incidence before the next exam is proposed. The
next screening time is found by limiting this probability to a small value, to guarantee early detection and
control the risk of over-diagnosis. The lead-time distribution and the probability of over-diagnosis are
derived, if one would be diagnosed with cancer at the next proposed screening time, so that predictive
information can be provided to individuals on how early his/her disease could be detected, and the risk of
over-diagnosis if one undergoes screening exams as suggested.
3. To develop a user-friendly software for Aims 1 and 2, and made available to the public.
In summary policy makers can use information from this research to recommend future screening frequencies
for different risk groups (e.g., age, gender, smoking status) under different screening techniques (X-ray or CT).
Physicians may use results from Aim 3 (the developed software) to schedule the next exam for individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Statistical Inference for Lead Time in Cancer Screening
-
批准号:6938206
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2005
-
负责人:Dongfeng Wu
-
依托单位:
Statistical Inference for Lead Time in Cancer Screening
-
批准号:7047845
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2005
-
负责人:Dongfeng Wu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: